Bortezomib and Alphagan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bortezomib (bortezomib) and Alphagan (brimonidine tartrate). Common drug interactions include peripheral sensorimotor neuropathy among females and cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Bortezomib and Alphagan. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

On Aug, 08, 2026

11 people who take Bortezomib and Alphagan together, and have interactions are studied.

Bortezomib and Alphagan drug interactions.

What are the common drug interactions of Bortezomib and Alphagan, by gender? *:

female:

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)

male:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Exposed bone in jaw
Gilbert's syndrome (liver condition in which the liver doesn't properly process a substance called bilirubin)
Lung disorder (lung disease)
Neuropathy peripheral (surface nerve damage)
Plasma cell myeloma (cancer that begins in plasma cells)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Bortezomib and Alphagan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Pyrexia (fever)
Pulmonary embolism (blockage of the main artery of the lung)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)

60+:

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Lung disorder (lung disease)
Neuropathy peripheral (surface nerve damage)
Plasma cell myeloma (cancer that begins in plasma cells)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Thrombocytopenia (decrease of platelets in blood)
Thyroid neoplasm (tumour of thyroid)
Tooth disorder (tooth disease)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%
Constipation: 3 people, 27.27%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 27.27%
Discomfort: 3 people, 27.27%
Uveitis (inflammation of the uvea): 3 people, 27.27%
Hyperglycemia (high blood sugar): 3 people, 27.27%
High Blood Pressure: 2 people, 18.18%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 9.09%
Cardiac Failure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Bortezomib and Alphagan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously